 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0008521	acetyl-CoA transporter activity	1	1.896623e-5	6.994746e-2	6.994746e-2	5.272530e+4	1.896623e-5	1	1.896623e-5	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC33A1
GO Molecular Function	GO:0051185	coenzyme transporter activity	2	2.608769e-4	9.621140e-1	4.810570e-1	3.833225e+3	2.608769e-4	1	2.608769e-4	1.000000e+0	2	4.433975e-4	1.000000e+0	8.176250e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	SLC33A1
GO Molecular Function	GO:0051184	cofactor transporter activity	3	8.259258e-4	1.000000e+0	1.000000e+0	1.210763e+3	8.259258e-4	1	8.259258e-4	1.000000e+0	3	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC33A1
GO Molecular Function	GO:0016788	hydrolase activity, acting on ester bonds	4	6.759571e-2	1.000000e+0	1.000000e+0	1.479384e+1	6.759571e-2	1	6.759571e-2	1.000000e+0	4	8.226776e-2	1.000000e+0	1.000000e+0	1.190040e+1	8.403082e-2	1	758	5.000000e-1	1.319261e-3	unnamed	C3orf33
GO Molecular Function	GO:0005215	transporter activity	5	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	5	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	SLC33A1
GO Molecular Function	GO:0016787	hydrolase activity	6	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	6	2.486583e-1	1.000000e+0	1.000000e+0	3.753849e+0	2.663932e-1	1	2403	5.000000e-1	4.161465e-4	unnamed	C3orf33
GO Molecular Function	GO:0003676	nucleic acid binding	7	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	7	3.411408e-1	1.000000e+0	1.000000e+0	2.655431e+0	3.765867e-1	1	3397	5.000000e-1	2.943774e-4	unnamed	C3orf33
GO Molecular Function	GO:1901363	heterocyclic compound binding	8	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	8	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	C3orf33
GO Molecular Function	GO:0097159	organic cyclic compound binding	9	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	9	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	C3orf33
GO Molecular Function	GO:0003824	catalytic activity	10	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	10	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	C3orf33
GO Molecular Function	GO:0005488	binding	11	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	11	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	C3orf33
GO Biological Process	GO:0015876	acetyl-CoA transport	1	1.896623e-5	1.980074e-1	1.980074e-1	5.272530e+4	1.896623e-5	1	1.896623e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC33A1
GO Biological Process	GO:0051182	coenzyme transport	2	2.629738e-4	1.000000e+0	1.000000e+0	3.802660e+3	2.629738e-4	1	2.629738e-4	1.000000e+0	2	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC33A1
GO Biological Process	GO:0051181	cofactor transport	3	9.443147e-4	1.000000e+0	1.000000e+0	1.058969e+3	9.443147e-4	1	9.443147e-4	1.000000e+0	3	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	SLC33A1
GO Biological Process	GO:0015711	organic anion transport	4	2.827900e-2	1.000000e+0	1.000000e+0	3.536193e+1	2.827900e-2	1	2.827900e-2	1.000000e+0	4	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	SLC33A1
GO Biological Process	GO:0006820	anion transport	5	3.528482e-2	1.000000e+0	1.000000e+0	2.834080e+1	3.528482e-2	1	3.528482e-2	1.000000e+0	5	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	SLC33A1
GO Biological Process	GO:0055085	transmembrane transport	6	8.563981e-2	1.000000e+0	1.000000e+0	1.167681e+1	8.563981e-2	1	8.563981e-2	1.000000e+0	6	9.602230e-2	1.000000e+0	1.000000e+0	1.015822e+1	9.844244e-2	1	888	5.000000e-1	1.126126e-3	unnamed	SLC33A1
GO Biological Process	GO:0006811	ion transport	7	1.070764e-1	1.000000e+0	1.000000e+0	9.339125e+0	1.070764e-1	1	1.070764e-1	1.000000e+0	7	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	SLC33A1
GO Biological Process	GO:0008219	cell death	8	1.161348e-1	1.000000e+0	1.000000e+0	8.610686e+0	1.161348e-1	1	1.161348e-1	1.000000e+0	8	1.323311e-1	1.000000e+0	1.000000e+0	7.298139e+0	1.370212e-1	1	1236	5.000000e-1	8.090615e-4	unnamed	SLC33A1
GO Biological Process	GO:0016265	death	9	1.165949e-1	1.000000e+0	1.000000e+0	8.576703e+0	1.165949e-1	1	1.165949e-1	1.000000e+0	9	1.326408e-1	1.000000e+0	1.000000e+0	7.280468e+0	1.373538e-1	1	1239	5.000000e-1	8.071025e-4	unnamed	SLC33A1
GO Biological Process	GO:0071702	organic substance transport	10	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	10	1.786811e-1	1.000000e+0	1.000000e+0	5.334418e+0	1.874619e-1	1	1691	5.000000e-1	5.913661e-4	unnamed	SLC33A1
GO Biological Process	GO:0044765	single-organism transport	11	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	11	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	SLC33A1
GO Biological Process	GO:0006810	transport	12	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	12	3.291182e-1	1.000000e+0	1.000000e+0	2.763634e+0	3.618425e-1	1	3264	5.000000e-1	3.063725e-4	unnamed	SLC33A1
GO Biological Process	GO:0051234	establishment of localization	13	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	13	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	SLC33A1
GO Biological Process	GO:0051179	localization	14	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	14	3.970433e-1	1.000000e+0	1.000000e+0	2.237227e+0	4.469819e-1	1	4032	5.000000e-1	2.480159e-4	unnamed	SLC33A1
GO Biological Process	GO:0044763	single-organism cellular process	15	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	15	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	SLC33A1
GO Biological Process	GO:0044699	single-organism process	16	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	16	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	SLC33A1
GO Biological Process	GO:0009987	cellular process	17	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	17	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	SLC33A1
GO Cellular Component	GO:0000139	Golgi membrane	1	5.778206e-2	1.000000e+0	1.000000e+0	1.730641e+1	5.778206e-2	1	5.778206e-2	1.000000e+0	1	6.015194e-2	1.000000e+0	1.000000e+0	1.637114e+1	6.108309e-2	1	551	5.000000e-1	1.814882e-3	unnamed	SLC33A1
GO Cellular Component	GO:0005789	endoplasmic reticulum membrane	2	6.490642e-2	1.000000e+0	1.000000e+0	1.540680e+1	6.490642e-2	1	6.490642e-2	1.000000e+0	4	8.534508e-2	1.000000e+0	1.000000e+0	1.146188e+1	8.724572e-2	1	787	5.000000e-1	1.270648e-3	unnamed	SLC33A1
GO Cellular Component	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	3	6.714499e-2	1.000000e+0	1.000000e+0	1.489314e+1	6.714499e-2	1	6.714499e-2	1.000000e+0	5	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	SLC33A1
GO Cellular Component	GO:0044431	Golgi apparatus part	4	7.015260e-2	1.000000e+0	1.000000e+0	1.425464e+1	7.015260e-2	1	7.015260e-2	1.000000e+0	2	7.321825e-2	1.000000e+0	1.000000e+0	1.340342e+1	7.460784e-2	1	673	5.000000e-1	1.485884e-3	unnamed	SLC33A1
GO Cellular Component	GO:0044432	endoplasmic reticulum part	5	7.857548e-2	1.000000e+0	1.000000e+0	1.272662e+1	7.857548e-2	1	7.857548e-2	1.000000e+0	7	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	SLC33A1
GO Cellular Component	GO:0005783	endoplasmic reticulum	6	1.167593e-1	1.000000e+0	1.000000e+0	8.564628e+0	1.167593e-1	1	1.167593e-1	1.000000e+0	12	1.436532e-1	1.000000e+0	1.000000e+0	6.701709e+0	1.492157e-1	1	1346	5.000000e-1	7.429421e-4	unnamed	SLC33A1
GO Cellular Component	GO:0005794	Golgi apparatus	7	1.250692e-1	1.000000e+0	1.000000e+0	7.995574e+0	1.250692e-1	1	1.250692e-1	1.000000e+0	9	1.300577e-1	1.000000e+0	1.000000e+0	7.430395e+0	1.345823e-1	1	1214	5.000000e-1	8.237232e-4	unnamed	SLC33A1
GO Cellular Component	GO:0005887	integral to plasma membrane	8	1.462434e-1	1.000000e+0	1.000000e+0	6.837917e+0	1.462434e-1	1	1.462434e-1	1.000000e+0	10	1.333634e-1	1.000000e+0	1.000000e+0	7.239567e+0	1.381298e-1	1	1246	5.000000e-1	8.025682e-4	unnamed	SLC33A1
GO Cellular Component	GO:0031226	intrinsic to plasma membrane	9	1.513797e-1	1.000000e+0	1.000000e+0	6.605906e+0	1.513797e-1	1	1.513797e-1	1.000000e+0	11	1.383102e-1	1.000000e+0	1.000000e+0	6.971020e+0	1.434510e-1	1	1294	5.000000e-1	7.727975e-4	unnamed	SLC33A1
GO Cellular Component	GO:0012505	endomembrane system	10	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	13	1.741537e-1	1.000000e+0	1.000000e+0	5.480255e+0	1.824733e-1	1	1646	5.000000e-1	6.075334e-4	unnamed	SLC33A1
GO Cellular Component	GO:0031090	organelle membrane	11	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	16	2.650007e-1	1.000000e+0	1.000000e+0	3.504468e+0	2.853500e-1	1	2574	5.000000e-1	3.885004e-4	unnamed	SLC33A1
GO Cellular Component	GO:0044459	plasma membrane part	12	2.354746e-1	1.000000e+0	1.000000e+0	4.246743e+0	2.354746e-1	1	2.354746e-1	1.000000e+0	15	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	SLC33A1
GO Cellular Component	GO:0005886	plasma membrane	13	4.126577e-1	1.000000e+0	1.000000e+0	2.423316e+0	4.126577e-1	1	4.126577e-1	1.000000e+0	17	4.264607e-1	1.000000e+0	1.000000e+0	2.060416e+0	4.853390e-1	1	4378	5.000000e-1	2.284148e-4	unnamed	SLC33A1
GO Cellular Component	GO:0071944	cell periphery	14	4.194602e-1	1.000000e+0	1.000000e+0	2.384017e+0	4.194602e-1	1	4.194602e-1	1.000000e+0	18	4.347424e-1	1.000000e+0	1.000000e+0	2.014854e+0	4.963140e-1	1	4477	5.000000e-1	2.233639e-4	unnamed	SLC33A1
GO Cellular Component	GO:0016021	integral to membrane	15	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	3	8.502701e-2	1.000000e+0	1.000000e+0	3.429196e+0	5.832271e-1	2	5261	1.000000e+0	3.801559e-4	unnamed	C3orf33,SLC33A1
GO Cellular Component	GO:0031224	intrinsic to membrane	16	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	6	8.871915e-2	1.000000e+0	1.000000e+0	3.357090e+0	5.957541e-1	2	5374	1.000000e+0	3.721623e-4	unnamed	C3orf33,SLC33A1
GO Cellular Component	GO:0044446	intracellular organelle part	17	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	19	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	SLC33A1
GO Cellular Component	GO:0044422	organelle part	18	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	20	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	SLC33A1
GO Cellular Component	GO:0044444	cytoplasmic part	19	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	21	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	SLC33A1
GO Cellular Component	GO:0044425	membrane part	20	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	8	1.178243e-1	1.000000e+0	1.000000e+0	2.913128e+0	6.865473e-1	2	6193	1.000000e+0	3.229453e-4	unnamed	C3orf33,SLC33A1
GO Cellular Component	GO:0016020	membrane	21	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	14	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	C3orf33,SLC33A1
GO Cellular Component	GO:0005737	cytoplasm	22	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	22	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	SLC33A1
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	23	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	23	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	SLC33A1
GO Cellular Component	GO:0043227	membrane-bounded organelle	24	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	24	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	SLC33A1
GO Cellular Component	GO:0043229	intracellular organelle	25	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	25	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	SLC33A1
GO Cellular Component	GO:0043226	organelle	26	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	26	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	SLC33A1
GO Cellular Component	GO:0044424	intracellular part	27	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	27	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	SLC33A1
GO Cellular Component	GO:0005622	intracellular	28	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	28	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	SLC33A1
GO Cellular Component	GO:0044464	cell part	29	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	29	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	SLC33A1
GO Cellular Component	GO:0005623	cell	30	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	30	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	SLC33A1
Human Phenotype	HP:0010837	Decreased serum ceruloplasmin	1	1.896623e-5	1.165664e-1	1.165664e-1	5.272530e+4	1.896623e-5	1	1.896623e-5	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC33A1
Human Phenotype	HP:0010836	Abnormality of copper homeostasis	2	7.261714e-5	4.463049e-1	2.231525e-1	1.377085e+4	7.261714e-5	1	7.261714e-5	1.000000e+0	2	2.217111e-4	1.000000e+0	6.813182e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC33A1
Human Phenotype	HP:0003429	Hypomyelination	3	7.305784e-4	1.000000e+0	1.000000e+0	1.368778e+3	7.305784e-4	1	7.305784e-4	1.000000e+0	3	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	SLC33A1
Human Phenotype	HP:0011030	Abnormality of transition element cation homeostasis	4	9.412476e-4	1.000000e+0	1.000000e+0	1.062420e+3	9.412476e-4	1	9.412476e-4	1.000000e+0	5	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	SLC33A1
Human Phenotype	HP:0002064	Spastic gait	5	1.321977e-3	1.000000e+0	1.000000e+0	7.564430e+2	1.321977e-3	1	1.321977e-3	1.000000e+0	6	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC33A1
Human Phenotype	HP:0002395	Lower limb hyperreflexia	6	1.504356e-3	1.000000e+0	1.000000e+0	6.647361e+2	1.504356e-3	1	1.504356e-3	1.000000e+0	4	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	SLC33A1
Human Phenotype	HP:0001258	Spastic paraplegia	7	2.183638e-3	1.000000e+0	1.000000e+0	4.579514e+2	2.183638e-3	1	2.183638e-3	1.000000e+0	7	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	SLC33A1
Human Phenotype	HP:0010550	Paraplegia	8	2.299973e-3	1.000000e+0	1.000000e+0	4.347876e+2	2.299973e-3	1	2.299973e-3	1.000000e+0	8	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	SLC33A1
Human Phenotype	HP:0002061	Lower limb spasticity	9	4.355900e-3	1.000000e+0	1.000000e+0	2.295737e+2	4.355900e-3	1	4.355900e-3	1.000000e+0	10	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	SLC33A1
Human Phenotype	HP:0010551	Paraplegia/paraparesis	10	4.576718e-3	1.000000e+0	1.000000e+0	2.184972e+2	4.576718e-3	1	4.576718e-3	1.000000e+0	9	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	SLC33A1
Human Phenotype	HP:0011400	Abnormal CNS myelination	11	6.500457e-3	1.000000e+0	1.000000e+0	1.538353e+2	6.500457e-3	1	6.500457e-3	1.000000e+0	11	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	SLC33A1
Human Phenotype	HP:0001272	Cerebellar atrophy	12	7.839562e-3	1.000000e+0	1.000000e+0	1.275581e+2	7.839562e-3	1	7.839562e-3	1.000000e+0	13	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	SLC33A1
Human Phenotype	HP:0003487	Babinski sign	13	7.878417e-3	1.000000e+0	1.000000e+0	1.269291e+2	7.878417e-3	1	7.878417e-3	1.000000e+0	12	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	SLC33A1
Human Phenotype	HP:0010929	Abnormality of cation homeostasis	14	8.949772e-3	1.000000e+0	1.000000e+0	1.117347e+2	8.949772e-3	1	8.949772e-3	1.000000e+0	15	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	SLC33A1
Human Phenotype	HP:0012447	Abnormal myelination	15	1.038592e-2	1.000000e+0	1.000000e+0	9.628419e+1	1.038592e-2	1	1.038592e-2	1.000000e+0	18	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	SLC33A1
Human Phenotype	HP:0003676	Progressive disorder	16	1.041484e-2	1.000000e+0	1.000000e+0	9.601683e+1	1.041484e-2	1	1.041484e-2	1.000000e+0	16	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	SLC33A1
Human Phenotype	HP:0003111	Abnormality of ion homeostasis	17	1.104281e-2	1.000000e+0	1.000000e+0	9.055669e+1	1.104281e-2	1	1.104281e-2	1.000000e+0	17	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	SLC33A1
Human Phenotype	HP:0001761	Pes cavus	18	1.280411e-2	1.000000e+0	1.000000e+0	7.809993e+1	1.280411e-2	1	1.280411e-2	1.000000e+0	14	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	SLC33A1
Human Phenotype	HP:0001257	Spasticity	19	2.102269e-2	1.000000e+0	1.000000e+0	4.756765e+1	2.102269e-2	1	2.102269e-2	1.000000e+0	26	2.828851e-2	1.000000e+0	1.000000e+0	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	SLC33A1
Human Phenotype	HP:0010549	Paralysis due to lesions of the principle motor tracts	20	2.184856e-2	1.000000e+0	1.000000e+0	4.576962e+1	2.184856e-2	1	2.184856e-2	1.000000e+0	19	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC33A1
Human Phenotype	HP:0003679	Pace of progression	21	2.214217e-2	1.000000e+0	1.000000e+0	4.516270e+1	2.214217e-2	1	2.214217e-2	1.000000e+0	23	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	SLC33A1
Human Phenotype	HP:0002059	Cerebral atrophy	22	2.274528e-2	1.000000e+0	1.000000e+0	4.396517e+1	2.274528e-2	1	2.274528e-2	1.000000e+0	20	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	SLC33A1
Human Phenotype	HP:0007369	Atrophy/Degeneration affecting the cerebrum	23	2.306765e-2	1.000000e+0	1.000000e+0	4.335075e+1	2.306765e-2	1	2.306765e-2	1.000000e+0	21	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	SLC33A1
Human Phenotype	HP:0012444	Brain atrophy	24	2.343110e-2	1.000000e+0	1.000000e+0	4.267832e+1	2.343110e-2	1	2.343110e-2	1.000000e+0	22	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	SLC33A1
Human Phenotype	HP:0007367	Atrophy/Degeneration affecting the central nervous system	25	2.578991e-2	1.000000e+0	1.000000e+0	3.877485e+1	2.578991e-2	1	2.578991e-2	1.000000e+0	24	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	SLC33A1
Human Phenotype	HP:0003593	Infantile onset	26	2.620028e-2	1.000000e+0	1.000000e+0	3.816753e+1	2.620028e-2	1	2.620028e-2	1.000000e+0	25	2.806993e-2	1.000000e+0	1.000000e+0	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	SLC33A1
Human Phenotype	HP:0003202	Amyotrophy	27	2.705294e-2	1.000000e+0	1.000000e+0	3.696455e+1	2.705294e-2	1	2.705294e-2	1.000000e+0	27	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	SLC33A1
Human Phenotype	HP:0001347	Hyperreflexia	28	2.789222e-2	1.000000e+0	1.000000e+0	3.585229e+1	2.789222e-2	1	2.789222e-2	1.000000e+0	28	3.428974e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	312	5.000000e-1	3.205128e-3	unnamed	SLC33A1
Human Phenotype	HP:0001276	Hypertonia	29	3.644032e-2	1.000000e+0	1.000000e+0	2.744213e+1	3.644032e-2	1	3.644032e-2	1.000000e+0	29	4.135815e-2	1.000000e+0	1.000000e+0	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	SLC33A1
Human Phenotype	HP:0001324	Muscle weakness	30	3.916358e-2	1.000000e+0	1.000000e+0	2.553393e+1	3.916358e-2	1	3.916358e-2	1.000000e+0	32	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	SLC33A1
Human Phenotype	HP:0000518	Cataract	31	3.983177e-2	1.000000e+0	1.000000e+0	2.510559e+1	3.983177e-2	1	3.983177e-2	1.000000e+0	30	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	SLC33A1
Human Phenotype	HP:0000517	Abnormality of the lens	32	4.100359e-2	1.000000e+0	1.000000e+0	2.438811e+1	4.100359e-2	1	4.100359e-2	1.000000e+0	31	4.537010e-2	1.000000e+0	1.000000e+0	2.178865e+1	4.589546e-2	1	414	5.000000e-1	2.415459e-3	unnamed	SLC33A1
Human Phenotype	HP:0001317	Abnormality of the cerebellum	33	4.894940e-2	1.000000e+0	1.000000e+0	2.042926e+1	4.894940e-2	1	4.894940e-2	1.000000e+0	34	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	SLC33A1
Human Phenotype	HP:0000639	Nystagmus	34	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	33	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	SLC33A1
Human Phenotype	HP:0011007	Age of onset	35	5.358267e-2	1.000000e+0	1.000000e+0	1.866275e+1	5.358267e-2	1	5.358267e-2	1.000000e+0	37	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	SLC33A1
Human Phenotype	HP:0003674	Onset	36	5.502040e-2	1.000000e+0	1.000000e+0	1.817508e+1	5.502040e-2	1	5.502040e-2	1.000000e+0	41	6.530370e-2	1.000000e+0	1.000000e+0	1.505927e+1	6.640430e-2	1	599	5.000000e-1	1.669449e-3	unnamed	SLC33A1
Human Phenotype	HP:0001263	Global developmental delay	37	5.775253e-2	1.000000e+0	1.000000e+0	1.731526e+1	5.775253e-2	1	5.775253e-2	1.000000e+0	38	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	SLC33A1
Human Phenotype	HP:0000496	Abnormality of eye movement	38	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	36	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	SLC33A1
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	39	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	39	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	SLC33A1
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	40	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	40	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	SLC33A1
Human Phenotype	HP:0011805	Abnormality of muscle morphology	41	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	43	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	SLC33A1
Human Phenotype	HP:0004328	Abnormality of the anterior segment of the eye	42	6.610995e-2	1.000000e+0	1.000000e+0	1.512632e+1	6.610995e-2	1	6.610995e-2	1.000000e+0	42	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	SLC33A1
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	43	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	44	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	SLC33A1
Human Phenotype	HP:0001760	Abnormality of the foot	44	7.004590e-2	1.000000e+0	1.000000e+0	1.427635e+1	7.004590e-2	1	7.004590e-2	1.000000e+0	35	6.176339e-2	1.000000e+0	1.000000e+0	1.593728e+1	6.274597e-2	1	566	5.000000e-1	1.766784e-3	unnamed	SLC33A1
Human Phenotype	HP:0000365	Hearing impairment	45	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	45	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	SLC33A1
Human Phenotype	HP:0000364	Hearing abnormality	46	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	46	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	SLC33A1
Human Phenotype	HP:0002060	Abnormality of the cerebrum	47	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	48	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	SLC33A1
Human Phenotype	HP:0100547	Abnormality of the forebrain	48	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	49	7.918527e-2	1.000000e+0	1.000000e+0	1.237380e+1	8.081592e-2	1	729	5.000000e-1	1.371742e-3	unnamed	SLC33A1
Human Phenotype	HP:0001250	Seizures	49	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	50	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	SLC33A1
Human Phenotype	HP:0011442	Abnormality of central motor function	50	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	51	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	SLC33A1
Human Phenotype	HP:0002814	Abnormality of the lower limb	51	8.121304e-2	1.000000e+0	1.000000e+0	1.231329e+1	8.121304e-2	1	8.121304e-2	1.000000e+0	46	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	SLC33A1
Human Phenotype	HP:0000004	Onset and clinical course	52	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	55	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	SLC33A1
Human Phenotype	HP:0012443	Abnormality of the brain	53	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	54	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	SLC33A1
Human Phenotype	HP:0011804	Abnormality of muscle physiology	54	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	56	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	SLC33A1
Human Phenotype	HP:0002813	Abnormality of limb bone morphology	55	1.016983e-1	1.000000e+0	1.000000e+0	9.833005e+0	1.016983e-1	1	1.016983e-1	1.000000e+0	52	9.665462e-2	1.000000e+0	1.000000e+0	1.009004e+1	9.910759e-2	1	894	5.000000e-1	1.118568e-3	unnamed	SLC33A1
Human Phenotype	HP:0011844	Abnormal appendicular skeleton morphology	56	1.019563e-1	1.000000e+0	1.000000e+0	9.808128e+0	1.019563e-1	1	1.019563e-1	1.000000e+0	53	9.728672e-2	1.000000e+0	1.000000e+0	1.002278e+1	9.977274e-2	1	900	5.000000e-1	1.111111e-3	unnamed	SLC33A1
Human Phenotype	HP:0000598	Abnormality of the ear	57	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	57	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	SLC33A1
Human Phenotype	HP:0012373	Abnormal eye physiology	58	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	58	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	SLC33A1
Human Phenotype	HP:0012374	Abnormality of the globe	59	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	59	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	SLC33A1
Human Phenotype	HP:0012372	Abnormal eye morphology	60	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	60	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	SLC33A1
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	61	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	65	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	SLC33A1
Human Phenotype	HP:0003011	Abnormality of the musculature	62	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	62	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	SLC33A1
Human Phenotype	HP:0000006	Autosomal dominant inheritance	63	1.208130e-1	1.000000e+0	1.000000e+0	8.277255e+0	1.208130e-1	1	1.208130e-1	1.000000e+0	61	1.191667e-1	1.000000e+0	1.000000e+0	8.133904e+0	1.229422e-1	1	1109	5.000000e-1	9.017133e-4	unnamed	SLC33A1
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	64	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	63	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	SLC33A1
Human Phenotype	HP:0100543	Cognitive impairment	65	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	64	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	SLC33A1
Human Phenotype	HP:0000007	Autosomal recessive inheritance	66	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	70	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	SLC33A1
Human Phenotype	HP:0000478	Abnormality of the eye	67	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	66	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	SLC33A1
Human Phenotype	HP:0011446	Abnormality of higher mental function	68	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	67	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	SLC33A1
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	69	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	68	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	SLC33A1
Human Phenotype	HP:0000924	Abnormality of the skeletal system	70	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	69	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	SLC33A1
Human Phenotype	HP:0002011	Abnormality of the central nervous system	71	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	71	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	SLC33A1
Human Phenotype	HP:0000707	Abnormality of the nervous system	72	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	72	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	SLC33A1
Human Phenotype	HP:0000005	Mode of inheritance	73	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	73	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	SLC33A1
Human Phenotype	HP:0000118	Phenotypic abnormality	74	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	74	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	SLC33A1
Human Phenotype	HP:0000001	All	75	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	75	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	SLC33A1
Disease Ontology	DOID:607	paraplegia	1	1.137274e-3	1.000000e+0	1.000000e+0	8.792953e+2	1.137274e-3	1	1.137274e-3	1.000000e+0	1	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	SLC33A1
Disease Ontology	DOID:331	central nervous system disease	2	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	2	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	SLC33A1
Disease Ontology	DOID:863	nervous system disease	3	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	3	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	SLC33A1
Disease Ontology	DOID:7	disease of anatomical entity	4	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	4	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	SLC33A1
Disease Ontology	DOID:4	disease	5	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	5	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_PTEN	Neighborhood of PTEN	1	7.917978e-3	1.000000e+0	1.000000e+0	1.262949e+2	7.917978e-3	1	7.917978e-3	1.000000e+0	1	9.290700e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_CASP10	Neighborhood of CASP10	2	1.123759e-2	1.000000e+0	1.000000e+0	8.898702e+1	1.123759e-2	1	1.123759e-2	1.000000e+0	2	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_RUNX1	Neighborhood of RUNX1	3	1.543608e-2	1.000000e+0	1.000000e+0	6.478329e+1	1.543608e-2	1	1.543608e-2	1.000000e+0	3	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_PSMF1	Neighborhood of PSMF1	4	1.555694e-2	1.000000e+0	1.000000e+0	6.428000e+1	1.555694e-2	1	1.555694e-2	1.000000e+0	4	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_BNIP1	Neighborhood of BNIP1	5	1.853847e-2	1.000000e+0	1.000000e+0	5.394190e+1	1.853847e-2	1	1.853847e-2	1.000000e+0	10	2.007505e-2	1.000000e+0	8.572046e-1	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_STK17A	Neighborhood of STK17A	6	1.873813e-2	1.000000e+0	1.000000e+0	5.336711e+1	1.873813e-2	1	1.873813e-2	1.000000e+0	5	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_PPP2R5B	Neighborhood of PPP2R5B	7	1.982787e-2	1.000000e+0	1.000000e+0	5.043407e+1	1.982787e-2	1	1.982787e-2	1.000000e+0	6	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_TNFRSF6	Neighborhood of TNFRSF6	8	2.271679e-2	1.000000e+0	1.000000e+0	4.402031e+1	2.271679e-2	1	2.271679e-2	1.000000e+0	8	1.897731e-2	1.000000e+0	1.000000e+0	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_TFDP2	Neighborhood of TFDP2	9	2.323768e-2	1.000000e+0	1.000000e+0	4.303356e+1	2.323768e-2	1	2.323768e-2	1.000000e+0	12	2.533565e-2	1.000000e+0	9.015269e-1	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_DMPK	Neighborhood of DMPK	10	2.385302e-2	1.000000e+0	1.000000e+0	4.192341e+1	2.385302e-2	1	2.385302e-2	1.000000e+0	7	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_MSH3	Neighborhood of MSH3	11	2.442404e-2	1.000000e+0	9.480968e-1	4.094327e+1	2.442404e-2	1	2.442404e-2	1.000000e+0	13	2.610163e-2	1.000000e+0	8.573382e-1	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_IL13	Neighborhood of IL13	12	2.492481e-2	1.000000e+0	8.869078e-1	4.012067e+1	2.492481e-2	1	2.492481e-2	1.000000e+0	11	2.467884e-2	1.000000e+0	9.579877e-1	4.027009e+1	2.483233e-2	1	224	5.000000e-1	4.464286e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_PRKCA	Neighborhood of PRKCA	13	2.828491e-2	1.000000e+0	9.290505e-1	3.535454e+1	2.828491e-2	1	2.828491e-2	1.000000e+0	9	1.952626e-2	1.000000e+0	9.264126e-1	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_BRCA1	Neighborhood of BRCA1	14	2.868559e-2	1.000000e+0	8.749105e-1	3.486070e+1	2.868559e-2	1	2.868559e-2	1.000000e+0	17	2.927180e-2	1.000000e+0	7.352387e-1	3.391165e+1	2.948839e-2	1	266	5.000000e-1	3.759398e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_IL16	Neighborhood of IL16	15	3.048858e-2	1.000000e+0	8.679082e-1	3.279917e+1	3.048858e-2	1	3.048858e-2	1.000000e+0	14	2.664858e-2	1.000000e+0	8.127817e-1	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_NOS2A	Neighborhood of NOS2A	16	3.524643e-2	1.000000e+0	9.406391e-1	2.837167e+1	3.524643e-2	1	3.524643e-2	1.000000e+0	20	3.156421e-2	1.000000e+0	6.738959e-1	3.143031e+1	3.181642e-2	1	287	5.000000e-1	3.484321e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_MDM2	Neighborhood of MDM2	17	3.546167e-2	1.000000e+0	8.907137e-1	2.819946e+1	3.546167e-2	1	3.546167e-2	1.000000e+0	18	3.090952e-2	1.000000e+0	7.332425e-1	3.210142e+1	3.115127e-2	1	281	5.000000e-1	3.558719e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_MAGEA8	Neighborhood of MAGEA8	18	3.765276e-2	1.000000e+0	8.932071e-1	2.655848e+1	3.765276e-2	1	3.765276e-2	1.000000e+0	16	2.883484e-2	1.000000e+0	7.695298e-1	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_PTPRB	Neighborhood of PTPRB	19	3.813294e-2	1.000000e+0	8.569877e-1	2.622404e+1	3.813294e-2	1	3.813294e-2	1.000000e+0	15	2.817922e-2	1.000000e+0	8.021685e-1	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_ARL3	Neighborhood of ARL3	20	3.850327e-2	1.000000e+0	8.220448e-1	2.597182e+1	3.850327e-2	1	3.850327e-2	1.000000e+0	22	3.330900e-2	1.000000e+0	6.464974e-1	2.977063e+1	3.359016e-2	1	303	5.000000e-1	3.300330e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_MLLT10	Neighborhood of MLLT10	21	4.008322e-2	1.000000e+0	8.150255e-1	2.494810e+1	4.008322e-2	1	4.008322e-2	1.000000e+0	22	3.330900e-2	1.000000e+0	6.464974e-1	2.977063e+1	3.359016e-2	1	303	5.000000e-1	3.300330e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_CAMK4	Neighborhood of CAMK4	22	4.061359e-2	1.000000e+0	7.882729e-1	2.462230e+1	4.061359e-2	1	4.061359e-2	1.000000e+0	21	3.210963e-2	1.000000e+0	6.528958e-1	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_FSHR	Neighborhood of FSHR	23	4.103835e-2	1.000000e+0	7.618859e-1	2.436745e+1	4.103835e-2	1	4.103835e-2	1.000000e+0	19	3.101865e-2	1.000000e+0	6.971033e-1	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_ERCC4	Neighborhood of ERCC4	24	4.310791e-2	1.000000e+0	7.669616e-1	2.319760e+1	4.310791e-2	1	4.310791e-2	1.000000e+0	24	3.548776e-2	1.000000e+0	6.313864e-1	2.792724e+1	3.580733e-2	1	323	5.000000e-1	3.095975e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_SUPT3H	Neighborhood of SUPT3H	25	4.765895e-2	1.000000e+0	8.140149e-1	2.098242e+1	4.765895e-2	1	4.765895e-2	1.000000e+0	26	3.624975e-2	1.000000e+0	5.953324e-1	2.733485e+1	3.658334e-2	1	330	5.000000e-1	3.030303e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_ATF2	Neighborhood of ATF2	26	4.769984e-2	1.000000e+0	7.833781e-1	2.096443e+1	4.769984e-2	1	4.769984e-2	1.000000e+0	25	3.614091e-2	1.000000e+0	6.172867e-1	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_FOSL1	Neighborhood of FOSL1	27	4.935019e-2	1.000000e+0	7.804641e-1	2.026335e+1	4.935019e-2	1	4.935019e-2	1.000000e+0	28	4.417824e-2	1.000000e+0	6.737182e-1	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_RAD51L3	Neighborhood of RAD51L3	28	5.515489e-2	1.000000e+0	8.411121e-1	1.813076e+1	5.515489e-2	1	5.515489e-2	1.000000e+0	27	4.244329e-2	1.000000e+0	6.712328e-1	2.330879e+1	4.290228e-2	1	387	5.000000e-1	2.583979e-3	unnamed	SLC33A1
MSigDB Cancer Neighborhood	MORF_MAGEA9	Neighborhood of MAGEA9	29	5.746388e-2	1.000000e+0	8.461061e-1	1.740224e+1	5.746388e-2	1	5.746388e-2	1.000000e+0	29	4.623645e-2	1.000000e+0	6.807919e-1	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	SLC33A1
MSigDB Pathway	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	Glycosphingolipid biosynthesis - ganglio series	1	1.476502e-3	1.000000e+0	1.000000e+0	6.772762e+2	1.476502e-3	1	1.476502e-3	1.000000e+0	1	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	SLC33A1
MSigDB Pathway	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	Genes involved in Transport of vitamins, nucleosides, and related molecules	2	2.788727e-3	1.000000e+0	1.000000e+0	3.585866e+2	2.788727e-3	1	2.788727e-3	1.000000e+0	2	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	SLC33A1
MSigDB Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	Genes involved in SLC-mediated transmembrane transport	3	2.225408e-2	1.000000e+0	1.000000e+0	4.493558e+1	2.225408e-2	1	2.225408e-2	1.000000e+0	3	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	SLC33A1
MSigDB Pathway	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	Genes involved in Transmembrane transport of small molecules	4	3.726554e-2	1.000000e+0	1.000000e+0	2.683444e+1	3.726554e-2	1	3.726554e-2	1.000000e+0	4	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	SLC33A1
MGI Expression: Detected	7902	TS24_brain	1	1.531351e-1	1.000000e+0	1.000000e+0	6.530182e+0	1.531351e-1	1	1.531351e-1	1.000000e+0	1	1.066368e-1	1.000000e+0	1.000000e+0	9.120829e+0	1.096392e-1	1	989	5.000000e-1	1.011122e-3	unnamed	SLC33A1
MGI Expression: Detected	7609	TS24_central nervous system	2	1.772412e-1	1.000000e+0	1.000000e+0	5.642029e+0	1.772412e-1	1	1.772412e-1	1.000000e+0	2	1.289199e-1	1.000000e+0	1.000000e+0	7.498337e+0	1.333629e-1	1	1203	5.000000e-1	8.312552e-4	unnamed	SLC33A1
MGI Expression: Detected	7502	TS24_nervous system	3	1.818348e-1	1.000000e+0	1.000000e+0	5.499496e+0	1.818348e-1	1	1.818348e-1	1.000000e+0	3	1.340857e-1	1.000000e+0	1.000000e+0	7.199122e+0	1.389058e-1	1	1253	5.000000e-1	7.980846e-4	unnamed	SLC33A1
MGI Expression: Detected	7446	TS24_organ system	4	2.979509e-1	1.000000e+0	1.000000e+0	3.356258e+0	2.979509e-1	1	2.979509e-1	1.000000e+0	4	2.626226e-1	1.000000e+0	1.000000e+0	3.538839e+0	2.825786e-1	1	2549	5.000000e-1	3.923107e-4	unnamed	SLC33A1
MGI Expression: Detected	6928	TS24_embryo	5	3.290828e-1	1.000000e+0	1.000000e+0	3.038749e+0	3.290828e-1	1	3.290828e-1	1.000000e+0	5	2.959376e-1	1.000000e+0	1.000000e+0	3.107303e+0	3.218225e-1	1	2903	5.000000e-1	3.444712e-4	unnamed	SLC33A1
MGI Expression: Detected	6927	Theiler_stage_24	6	3.296590e-1	1.000000e+0	1.000000e+0	3.033437e+0	3.296590e-1	1	3.296590e-1	1.000000e+0	6	2.964026e-1	1.000000e+0	1.000000e+0	3.101960e+0	3.223768e-1	1	2908	5.000000e-1	3.438790e-4	unnamed	SLC33A1
MGI Expression: Detected	6365	TS22_brain	7	3.486991e-1	1.000000e+0	1.000000e+0	2.867802e+0	3.486991e-1	1	3.486991e-1	1.000000e+0	7	2.970534e-1	1.000000e+0	1.000000e+0	3.094511e+0	3.231528e-1	1	2915	5.000000e-1	3.430532e-4	unnamed	SLC33A1
MGI Expression: Detected	6351	TS22_central nervous system	8	3.611614e-1	1.000000e+0	1.000000e+0	2.768845e+0	3.611614e-1	1	3.611614e-1	1.000000e+0	8	3.110186e-1	1.000000e+0	1.000000e+0	2.942107e+0	3.398925e-1	1	3066	5.000000e-1	3.261579e-4	unnamed	SLC33A1
MGI Expression: Detected	6350	TS22_nervous system	9	3.685477e-1	1.000000e+0	1.000000e+0	2.713353e+0	3.685477e-1	1	3.685477e-1	1.000000e+0	9	3.206469e-1	1.000000e+0	1.000000e+0	2.844686e+0	3.515326e-1	1	3171	5.000000e-1	3.153579e-4	unnamed	SLC33A1
MGI Expression: Detected	5784	TS22_organ system	10	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	10	4.454434e-1	1.000000e+0	1.000000e+0	1.958424e+0	5.106147e-1	1	4606	5.000000e-1	2.171081e-4	unnamed	SLC33A1
MGI Expression: Detected	5741	TS22_embryo	11	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	11	4.751674e-1	1.000000e+0	1.000000e+0	1.814625e+0	5.510781e-1	1	4971	5.000000e-1	2.011668e-4	unnamed	SLC33A1
MGI Expression: Detected	5740	Theiler_stage_22	12	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	12	4.770932e-1	1.000000e+0	1.000000e+0	1.805906e+0	5.537387e-1	1	4995	5.000000e-1	2.002002e-4	unnamed	SLC33A1
MSigDB Perturbation	CUI_GLUCOSE_DEPRIVATION	Representative genes up-regulated in MiaPaCa2 cells (pancreatic cancer) under glucose-deprived conditions.	1	4.603127e-3	1.000000e+0	1.000000e+0	2.172436e+2	4.603127e-3	1	4.603127e-3	1.000000e+0	5	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	SLC33A1
MSigDB Perturbation	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	Genes down-regulated in BJAB cell line (B lymphocyte) after expression of the viral microRNA miR-K12-11 which functions as an ortholog of cellular MIR155 [GeneID=406947].	2	6.219532e-3	1.000000e+0	1.000000e+0	1.607838e+2	6.219532e-3	1	6.219532e-3	1.000000e+0	4	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	SLC33A1
MSigDB Perturbation	GYORFFY_MITOXANTRONE_RESISTANCE	Genes associated with resistance to mitoxantrone [PubChem=4212].	3	8.041242e-3	1.000000e+0	1.000000e+0	1.243589e+2	8.041242e-3	1	8.041242e-3	1.000000e+0	2	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	SLC33A1
MSigDB Perturbation	BOYLAN_MULTIPLE_MYELOMA_C_DN	Genes down-regulated in group C of tumors arising from overexpression of BCL2L1 and MYC [GeneID=598;4609] in plasma cells.	4	9.678599e-3	1.000000e+0	1.000000e+0	1.033207e+2	9.678599e-3	1	9.678599e-3	1.000000e+0	3	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	C3orf33
MSigDB Perturbation	ZWANG_EGF_INTERVAL_UP	Genes induced in the time interval between two pulses of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	5	1.004585e-2	1.000000e+0	1.000000e+0	9.954360e+1	1.004585e-2	1	1.004585e-2	1.000000e+0	6	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	SLC33A1
MSigDB Perturbation	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	Down-regulated genes distinguishing in multiple myeloma (MM) samples with lower expression of TACI [GeneID=23495].	6	1.299140e-2	1.000000e+0	1.000000e+0	7.697401e+1	1.299140e-2	1	1.299140e-2	1.000000e+0	10	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	SLC33A1
MSigDB Perturbation	HOEBEKE_LYMPHOID_STEM_CELL_UP	Genes up-regulated in the common lymphoid progenitor (CLP, defined as CD34+CD38-CD7+ [GeneID=947;952;924]) compared to a multipotent cord blood cell (defined as CD34+CD38+CD7-).	7	1.301443e-2	1.000000e+0	1.000000e+0	7.683779e+1	1.301443e-2	1	1.301443e-2	1.000000e+0	7	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	SLC33A1
MSigDB Perturbation	SMITH_TERT_TARGETS_UP	Genes consistently up-regulated in HMEC cells (primary mammary epithelium) upon expression of TERT [GeneID=7015] off a retroviral vector.	8	1.607734e-2	1.000000e+0	1.000000e+0	6.219934e+1	1.607734e-2	1	1.607734e-2	1.000000e+0	9	1.601034e-2	1.000000e+0	1.000000e+0	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	SLC33A1
MSigDB Perturbation	LIU_SOX4_TARGETS_UP	Genes up-regulated in LNCaP cells (prostate cancer) by overexpression of SOX4 [GeneID=6659] and down-regulated by its RNAi knockdown.	9	1.698269e-2	1.000000e+0	1.000000e+0	5.888350e+1	1.698269e-2	1	1.698269e-2	1.000000e+0	8	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	SLC33A1
MSigDB Perturbation	BLUM_RESPONSE_TO_SALIRASIB_UP	Selected genes up-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].	10	2.027921e-2	1.000000e+0	1.000000e+0	4.931158e+1	2.027921e-2	1	2.027921e-2	1.000000e+0	13	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	SLC33A1
MSigDB Perturbation	GRUETZMANN_PANCREATIC_CANCER_DN	Genes down-regulated in pancreatic ductal adenocarcinoma (PDAC) identified in a meta analysis across four independent studies.	11	2.192740e-2	1.000000e+0	1.000000e+0	4.560505e+1	2.192740e-2	1	2.192740e-2	1.000000e+0	11	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	SLC33A1
MSigDB Perturbation	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	Up-regulated genes in the cancer gene signature, representing a gene signature of cellular transformation.	12	2.364951e-2	1.000000e+0	1.000000e+0	4.228418e+1	2.364951e-2	1	2.364951e-2	1.000000e+0	12	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	SLC33A1
MSigDB Perturbation	DOUGLAS_BMI1_TARGETS_DN	Genes down-regulated in A4573 cells (Ewing's sarcoma, ESFT) after knockdown of BMI1 [GeneID=648] by RNAi.	13	3.048740e-2	1.000000e+0	1.000000e+0	3.280044e+1	3.048740e-2	1	3.048740e-2	1.000000e+0	15	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	SLC33A1
MSigDB Perturbation	HELLER_HDAC_TARGETS_DN	Genes down-regulated in at least one of three multiple myeloma (MM) cell lines by TSA [PubChem=5562].	14	3.672471e-2	1.000000e+0	1.000000e+0	2.722963e+1	3.672471e-2	1	3.672471e-2	1.000000e+0	14	3.156421e-2	1.000000e+0	1.000000e+0	3.143031e+1	3.181642e-2	1	287	5.000000e-1	3.484321e-3	unnamed	SLC33A1
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	15	4.262412e-2	1.000000e+0	1.000000e+0	2.346089e+1	4.262412e-2	1	4.262412e-2	1.000000e+0	22	6.519651e-2	1.000000e+0	1.000000e+0	1.508445e+1	6.629344e-2	1	598	5.000000e-1	1.672241e-3	unnamed	SLC33A1
MSigDB Perturbation	HAN_SATB1_TARGETS_UP	Genes up-regulated in MDA-MB-231 cells (breast cancer) after knockdown of SATB1 [GeneID=6304] by RNAi.	16	4.593672e-2	1.000000e+0	1.000000e+0	2.176908e+1	4.593672e-2	1	4.593672e-2	1.000000e+0	16	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	SLC33A1
MSigDB Perturbation	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	Genes commonly down-regulated in human alveolar rhabdomyosarcoma (ARMS) and its mouse model overexpressing PAX3-FOXO1 [GeneID=5077;2308] fusion.	17	4.599214e-2	1.000000e+0	1.000000e+0	2.174284e+1	4.599214e-2	1	4.599214e-2	1.000000e+0	17	4.461173e-2	1.000000e+0	1.000000e+0	2.216339e+1	4.511945e-2	1	407	5.000000e-1	2.457002e-3	unnamed	SLC33A1
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	Genes in the expression cluster 'Late Progenitors Shared': up-regulated in hematopoietic late progenitor cells from adult bone marrow and fetal liver.	18	4.669281e-2	1.000000e+0	1.000000e+0	2.141657e+1	4.669281e-2	1	4.669281e-2	1.000000e+0	20	5.649422e-2	1.000000e+0	1.000000e+0	1.744778e+1	5.731390e-2	1	517	5.000000e-1	1.934236e-3	unnamed	SLC33A1
MSigDB Perturbation	KIM_WT1_TARGETS_DN	Genes down-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	19	4.691887e-2	1.000000e+0	1.000000e+0	2.131339e+1	4.691887e-2	1	4.691887e-2	1.000000e+0	19	4.894124e-2	1.000000e+0	1.000000e+0	2.018009e+1	4.955379e-2	1	447	5.000000e-1	2.237136e-3	unnamed	SLC33A1
MSigDB Perturbation	HAN_SATB1_TARGETS_DN	Genes down-regulated in MDA-MB-231 cells (breast cancer) after knockdown of SATB1 [GeneID=6304] by RNAi.	20	5.266731e-2	1.000000e+0	1.000000e+0	1.898711e+1	5.266731e-2	1	5.266731e-2	1.000000e+0	18	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	SLC33A1
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	Genes up-regulated in liver tumor compared to the normal adjacent tissue.	21	6.025185e-2	1.000000e+0	1.000000e+0	1.659700e+1	6.025185e-2	1	6.025185e-2	1.000000e+0	26	9.169554e-2	1.000000e+0	1.000000e+0	1.064994e+1	9.389723e-2	1	847	5.000000e-1	1.180638e-3	unnamed	SLC33A1
MSigDB Perturbation	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	Down-regulated genes in peripheral zone of human pancreatic cancer growing in the pancreas of nude mice compared to that of the tumor from the central zone.	22	6.253641e-2	1.000000e+0	1.000000e+0	1.599068e+1	6.253641e-2	1	6.253641e-2	1.000000e+0	21	6.508932e-2	1.000000e+0	1.000000e+0	1.510972e+1	6.618258e-2	1	597	5.000000e-1	1.675042e-3	unnamed	SLC33A1
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	Genes in the expression cluster 'HSC and Progenitors Shared': up-regulated in hematopoietic stem cells (HSC) and progenitors from adult bone marrow and fetal liver.	23	7.135492e-2	1.000000e+0	1.000000e+0	1.401445e+1	7.135492e-2	1	7.135492e-2	1.000000e+0	1	1.288197e-3	1.000000e+0	1.000000e+0	2.784105e+1	7.183637e-2	2	648	1.000000e+0	3.086420e-3	unnamed	C3orf33,SLC33A1
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	24	7.551862e-2	1.000000e+0	1.000000e+0	1.324177e+1	7.551862e-2	1	7.551862e-2	1.000000e+0	28	1.189586e-1	1.000000e+0	1.000000e+0	8.148600e+0	1.227205e-1	1	1107	5.000000e-1	9.033424e-4	unnamed	SLC33A1
MSigDB Perturbation	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	Genes up-regulated in T24 (bladder cancer) cells in response to the photodynamic therapy (PDT) stress.	25	7.787022e-2	1.000000e+0	1.000000e+0	1.284188e+1	7.787022e-2	1	7.787022e-2	1.000000e+0	24	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	SLC33A1
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_UP	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	26	7.903216e-2	1.000000e+0	1.000000e+0	1.265308e+1	7.903216e-2	1	7.903216e-2	1.000000e+0	27	1.017052e-1	1.000000e+0	1.000000e+0	9.575902e+0	1.044288e-1	1	942	5.000000e-1	1.061571e-3	unnamed	SLC33A1
MSigDB Perturbation	NUYTTEN_NIPP1_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of NIPP1 [GeneID=5511] by RNAi.	27	8.459132e-2	1.000000e+0	1.000000e+0	1.182154e+1	8.459132e-2	1	8.459132e-2	1.000000e+0	23	8.014245e-2	1.000000e+0	1.000000e+0	1.222290e+1	8.181365e-2	1	738	5.000000e-1	1.355014e-3	unnamed	C3orf33
MSigDB Perturbation	CUI_TCF21_TARGETS_2_DN	All significantly down-regulated genes in kidney glomeruli isolated from TCF21 [Gene ID=6943] knockout mice.	28	1.186115e-1	1.000000e+0	1.000000e+0	8.430888e+0	1.186115e-1	1	1.186115e-1	1.000000e+0	25	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	SLC33A1
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_UP	Genes up-regulated in brain from patients with Alzheimer's disease.	29	1.561268e-1	1.000000e+0	1.000000e+0	6.405052e+0	1.561268e-1	1	1.561268e-1	1.000000e+0	30	1.768717e-1	1.000000e+0	1.000000e+0	5.391811e+0	1.854664e-1	1	1673	5.000000e-1	5.977286e-4	unnamed	SLC33A1
MSigDB Perturbation	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY	Genes transiently induced only by the first pulse of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	30	1.656740e-1	1.000000e+0	1.000000e+0	6.035952e+0	1.656740e-1	1	1.656740e-1	1.000000e+0	29	1.708257e-1	1.000000e+0	1.000000e+0	5.592374e+0	1.788149e-1	1	1613	5.000000e-1	6.199628e-4	unnamed	C3orf33
MSigDB Predicted Promoter Motifs	YNGTTNNNATT_UNKNOWN	Motif YNGTTNNNATT (no known TF)	1	6.955547e-2	1.000000e+0	1.000000e+0	1.437701e+1	6.955547e-2	1	6.955547e-2	1.000000e+0	1	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	SLC33A1
MSigDB Predicted Promoter Motifs	CACGTG_V$MYC_Q2	Motif CACGTG matches MYC: v-myc myelocytomatosis viral oncogene homolog (avian)	2	9.316007e-2	1.000000e+0	1.000000e+0	1.073421e+1	9.316007e-2	1	9.316007e-2	1.000000e+0	2	1.063225e-1	1.000000e+0	1.000000e+0	9.148580e+0	1.093066e-1	1	986	5.000000e-1	1.014199e-3	unnamed	SLC33A1
MSigDB miRNA Motifs	ACCAAAG,MIR-9	Targets of MicroRNA ACCAAAG,MIR-9	1	7.022342e-2	1.000000e+0	1.000000e+0	1.424026e+1	7.022342e-2	1	7.022342e-2	1.000000e+0	1	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	SLC33A1
InterPro	IPR004752	AmpG-like permease/Acetyl-coenzyme A transporter 1	1	1.896623e-5	1.786998e-1	1.786998e-1	5.272530e+4	1.896623e-5	1	1.896623e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC33A1
InterPro	IPR024371	Acetyl-coenzyme A transporter 1	1	1.896623e-5	1.786998e-1	1.786998e-1	5.272530e+4	1.896623e-5	1	1.896623e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC33A1
InterPro	IPR016071	Staphylococcal nuclease (SNase-like), OB-fold	3	9.009051e-4	1.000000e+0	1.000000e+0	1.109995e+3	9.009051e-4	1	9.009051e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	C3orf33
InterPro	IPR011701	Major facilitator superfamily	4	4.954318e-3	1.000000e+0	1.000000e+0	2.018441e+2	4.954318e-3	1	4.954318e-3	1.000000e+0	4	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	SLC33A1
InterPro	IPR016196	Major facilitator superfamily domain, general substrate transporter	5	1.002249e-2	1.000000e+0	1.000000e+0	9.977556e+1	1.002249e-2	1	1.002249e-2	1.000000e+0	5	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	SLC33A1
TreeFam	TF300008	SLC33A1	1	1.896623e-5	1.541196e-1	1.541196e-1	5.272530e+4	1.896623e-5	1	1.896623e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC33A1
TreeFam	TF313180	C3orf33	2	6.022998e-5	4.894288e-1	2.447144e-1	1.660303e+4	6.022998e-5	1	6.022998e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C3orf33
HGNC Gene Families	SLC	SLC	1	3.126915e-2	1.000000e+0	1.000000e+0	3.198041e+1	3.126915e-2	1	3.126915e-2	1.000000e+0	1	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	SLC33A1
Ensembl Genes	14051	SLC33A1	1	1.896623e-5	3.421698e-1	3.421698e-1	5.272530e+4	1.896623e-5	1	1.896623e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC33A1
Ensembl Genes	14050	C3orf33	2	6.022998e-5	1.000000e+0	5.433045e-1	1.660303e+4	6.022998e-5	1	6.022998e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C3orf33
MSigDB Oncogenic Signatures	MTOR_UP.V1_DN	Genes down-regulated by everolimus [PubChem = 6442177] in prostate tissue.	1	1.567187e-2	1.000000e+0	1.000000e+0	6.380858e+1	1.567187e-2	1	1.567187e-2	1.000000e+0	1	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	SLC33A1
MSigDB Oncogenic Signatures	PIGF_UP.V1_UP	Genes up-regulated in HUVEC cells (endothelium) by treatment with PIGF [Gene ID=5281].	2	2.376115e-2	1.000000e+0	1.000000e+0	4.208551e+1	2.376115e-2	1	2.376115e-2	1.000000e+0	2	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	SLC33A1
MSigDB Oncogenic Signatures	TBK1.DF_UP	Genes up-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	3	3.016091e-2	1.000000e+0	1.000000e+0	3.315549e+1	3.016091e-2	1	3.016091e-2	1.000000e+0	3	3.123689e-2	1.000000e+0	1.000000e+0	3.176232e+1	3.148384e-2	1	284	5.000000e-1	3.521127e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN	Genes down-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	1	1.526745e-2	1.000000e+0	1.000000e+0	6.549883e+1	1.526745e-2	1	1.526745e-2	1.000000e+0	7	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE2706_R848_VS_LPS_8H_STIM_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	2	1.528020e-2	1.000000e+0	1.000000e+0	6.544416e+1	1.528020e-2	1	1.528020e-2	1.000000e+0	1	1.601034e-2	1.000000e+0	1.000000e+0	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	C3orf33
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_ERYTHROBLAST_UP	Genes up-regulated in comparison of B cells versus erythroblasts.	3	1.533416e-2	1.000000e+0	1.000000e+0	6.521388e+1	1.533416e-2	1	1.533416e-2	1.000000e+0	13	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	C3orf33
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.	4	1.543044e-2	1.000000e+0	1.000000e+0	6.480697e+1	1.543044e-2	1	1.543044e-2	1.000000e+0	20	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	5	1.561705e-2	1.000000e+0	1.000000e+0	6.403257e+1	1.561705e-2	1	1.561705e-2	1.000000e+0	4	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	6	1.564725e-2	1.000000e+0	1.000000e+0	6.390901e+1	1.564725e-2	1	1.564725e-2	1.000000e+0	2	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP	Genes up-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.	7	1.657094e-2	1.000000e+0	1.000000e+0	6.034661e+1	1.657094e-2	1	1.657094e-2	1.000000e+0	3	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	Genes down-regulated in comparison of memory IgM B cells versus blood plasma cells.	8	1.661169e-2	1.000000e+0	1.000000e+0	6.019857e+1	1.661169e-2	1	1.661169e-2	1.000000e+0	23	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD8POS_DC_DN	Genes down-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD8 DCs.	9	1.677105e-2	1.000000e+0	1.000000e+0	5.962656e+1	1.677105e-2	1	1.677105e-2	1.000000e+0	21	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	Genes down-regulated in comparison of memory IgG IgA B cells versus blood plasma cells.	10	1.768949e-2	1.000000e+0	1.000000e+0	5.653073e+1	1.768949e-2	1	1.768949e-2	1.000000e+0	21	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP	Genes up-regulated in comparison of untreated mast cells versus mast cells treated with IgE at 2 h.	11	1.787339e-2	1.000000e+0	1.000000e+0	5.594910e+1	1.787339e-2	1	1.787339e-2	1.000000e+0	7	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN	Genes down-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	12	1.831053e-2	1.000000e+0	1.000000e+0	5.461338e+1	1.831053e-2	1	1.831053e-2	1.000000e+0	6	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with Gardiquimod (TLR7 agonist) at 8 h.	13	1.832169e-2	1.000000e+0	1.000000e+0	5.458011e+1	1.832169e-2	1	1.832169e-2	1.000000e+0	13	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE27786_CD4_VS_CD8_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells versus CD8 T cells.	14	1.837450e-2	1.000000e+0	1.000000e+0	5.442326e+1	1.837450e-2	1	1.837450e-2	1.000000e+0	11	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN	Genes down-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	15	1.856321e-2	1.000000e+0	1.000000e+0	5.387000e+1	1.856321e-2	1	1.856321e-2	1.000000e+0	10	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP	Genes up-regulated in comparison of plasmacytoid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	16	1.872221e-2	1.000000e+0	1.000000e+0	5.341248e+1	1.872221e-2	1	1.872221e-2	1.000000e+0	7	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP	Genes up-regulated in comparison of rested memory CD8 T cells from pmel-1 mice versus rested naive CD8 T cells from pmel-1 mice.	17	1.886145e-2	1.000000e+0	1.000000e+0	5.301819e+1	1.886145e-2	1	1.886145e-2	1.000000e+0	11	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	C3orf33
MSigDB Immunologic Signatures	GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes stimulated with anti-Valpha2 antibodies versus CD4 [GeneID=920] CD8 thymocytes stimulated with anti-beta5 antibodies.	18	1.907159e-2	1.000000e+0	1.000000e+0	5.243402e+1	1.907159e-2	1	1.907159e-2	1.000000e+0	13	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_8H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with CpG DNA (TLR9 agonist) at 8 h.	19	1.935295e-2	1.000000e+0	1.000000e+0	5.167171e+1	1.935295e-2	1	1.935295e-2	1.000000e+0	17	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	Genes up-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.	20	2.049593e-2	1.000000e+0	1.000000e+0	4.879017e+1	2.049593e-2	1	2.049593e-2	1.000000e+0	24	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with TGFB1 [GeneID=7040] versus those treated with TGFB3 [GeneID=7043] and IL6 [GeneID=3569].	21	2.059242e-2	1.000000e+0	1.000000e+0	4.856157e+1	2.059242e-2	1	2.059242e-2	1.000000e+0	13	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of memory CD8 T cells versus effector CD8 T cells.	22	2.082746e-2	1.000000e+0	1.000000e+0	4.801353e+1	2.082746e-2	1	2.082746e-2	1.000000e+0	17	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC33A1
MSigDB Immunologic Signatures	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP	Genes up-regulated in comparison of effector memory T cells versus central memory T cells from peripheral blood mononuclear cells (PBMC).	23	2.337970e-2	1.000000e+0	1.000000e+0	4.277215e+1	2.337970e-2	1	2.337970e-2	1.000000e+0	4	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	C3orf33
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Gardiquimod (TLR7 agonist) at 1 h.	24	2.350048e-2	1.000000e+0	1.000000e+0	4.255232e+1	2.350048e-2	1	2.350048e-2	1.000000e+0	17	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC33A1
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
